Citations

Showing 10 of 108119 citations.

Rational Dispersion for the Introduction of Transcatheter Mitral Valve Repair Into Clinical Practice
Holmes, David R. , Mack, Michael J.

Mayo Clinic

JAMA | March 15, 2019 | Volume: 321 | Issue: 11 | Pages: 1043

10.1001/jama.2019.1542 | PMID 30874762 Get It

A49 LACTOBACILLI DEGRADE WHEAT AMYLASE TRYPSIN INHIBITORS (ATI) TO AMELIORATE GUT DYSFUNCTION INDUCED BY IMMUNOGENIC WHEAT PROTEINS
Fernandez, A Caminero, Zevallos, Victor F. , Xuechen, Y, Jury, Jennifer , Alaedini, Armin , Berčík, Přemysl , Schuppan, Detlef, Fernández, Alberto Caminero, McCarville, Justin L. , Pigrau, Marc , Galipeau, Heather J. , Casqueiro, Javier , Murray, Joseph A. , Collins, Stephen Michael , Verdú, Elena F.

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | March 15, 2019 | Volume: 2 | Issue: Supplement_2 | Pages: 97-98

10.1093/jcag/gwz006.048 Get It

Catecholamine and Metanephrine Levels in Breast Milk Before and After Paraganglioma Resection
Dodd, Sarah E. , Martin, Yvette N. , Singh, Ravinder J.

Mayo Clinic

Breastfeeding Medicine | March 15, 2019 | Volume: 14 | Issue: 4 | Pages: 276-277

10.1089/bfm.2019.0018 | PMID 30874459 Get It

A220 SCREENING AND MANAGEMENT OF LYNCH SYNDROME IN CLINICAL PRACTICE
Jain, Avni , Shafer, Leigh Anne , Kim, C, Rothenmund, Heidi, Samadder, Jewel, Singh, Harminder , Gupta, Samir

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | March 15, 2019 | Volume: 2 | Issue: Supplement_2 | Pages: 430-431

10.1093/jcag/gwz006.219 Get It

Autologous transobturator sling as an alternative therapy for stress urinary incontinence
Laufer, J , Scasso, Santiago , Bentancor, Valeria, Bertoche, Cecilia, Elliott, Daniel S. , Sosa, Claudio

Mayo Clinic

International Journal of Gynecology & Obstetrics | March 15, 2019 | Volume: 145 | Issue: 3 | Pages: 300-305

10.1002/ijgo.12804 | PMID 30874306 Get It

AbstractObjectiveTo evaluate efficacy and outcomes of the autologous transobturator midurethral sling for treatment of stress urinary incontinence (SUI).MethodsIn a prospective cohort study, an autologous transobturator mid‐urethral sling was used to treat SUI among women attending a university hospital in Montevideo, Uruguay, from June 2017 to July 2018. In the first phase, autologous tissue of the abdominis rectus fascia was collected. In the second phase, the midurethral sling was placed via the transobturator approach. Outcomes were measured every 3 months by the International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms (ICIQ‐FLUTS) Score. Preoperative and postoperative results were compared by Wilcoxon test.ResultsEighteen women with a median age of 51 years were enrolled. The median follow‐up was 9 months (range 6–15 months). Overall, 17 women showed symptomatic improvement after the procedure. In a comparison of preoperative versus postoperative ICIQ‐FLUTS questionnaires, improvement in the incontinence subscore was observed at 3 (P<0.001), 6 (P<0.001), and 12 (P=0.008) months. No severe complications were observed.ConclusionUse of an autologous transobturator urethral sling was found to be technically feasible and safe for SUI, with good short‐term outcomes. Longer follow up and larger series are needed to validate the procedure.
Thoracic Aortic Dissection in Tetralogy of Fallot: A Review of the National Inpatient Sample Database
Egbe, Alexander C. , Miranda, William R. , Connolly, Heidi M. , Crestanello, Juan A.

Mayo Clinic

Journal of the American Heart Association | March 15, 2019 | Volume: 8 | Issue: 6 | Pages: No page available

10.1161/jaha.119.011943 | PMID 30871391 Get It

Background Thoracic aortic aneurysm is common in patients with tetralogy of Fallot ( TOF ); the incidence of thoracic aortic dissection ( TAD ) is unknown, but generally considered to be uncommon. The purpose of this study was to determine incidence and risk factors for TAD in TOF patients. Methods and Results This work is a retrospective review of the National Inpatient Sample ( NIS ) database for cases of ascending TAD among all hospital admissions in adults with TOF , 2000–2014. Of 18 353 admissions in TOF patients, 11 (0.06%; 6 per 10 000 admissions) of these were TAD ‐related admissions. For the TAD ‐related admissions, mean age was 49.8±7.2 years; aortic surgical interventions were performed during 8 of the admissions, and overall in‐hospital mortality was 45% (5 of 11). Risk factors associated with TAD ‐related admission were age >60 years (odds ratio, 2.41; 95% CI, 1.23–3.25; P =0.013), male sex ( odds ratio, 6.91; 95% CI, 4.85–8.54; P <0.001), and hypertension (odds ratio, 1.74; 95% CI, 1.06–3.19; P =0.037). Conclusions This is the first population‐based study of TAD outcomes in patients with TOF , and it showed a low risk of TAD in this population. This has important clinical implication with regard to surveillance and surgical intervention. Given that prevalence of thoracic aortic aneurysm is higher in TOF patients compared with the general population; therefore, making clinical decisions based on outcomes data and practice guidelines derived from patients with degenerative and bicuspid aortic valve–related aortopathies may lead to overtreatment . Further studies are required to better understand the pathobiology of this disease in order to make evidence‐based recommendations for surveillance and treatment.
Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer
Fritz, Andrew J. , Gerrard, Diana L., Hong, David I. , Rose, Joshua T., Ghule, Prachi N. , Bolf, Eric L. , Gordon, Jonathan , Tracy, Kirsten M. , Nickerson, Jeffrey A. , Wijnen, André J. van , Imbalzano, Anthony N. , Heath, Jessica L. , Frietze, Seth , Zaidi, Sayyed K. , Carr, Frances E. , Lian, Jane B. , Stein, Janet L. , Fritz, A J , Stein, Gary S , van Wijnen, Andre J , Tracy, Kirsten M , Gillis, Noelle E. , Rodriguez, Princess D. , Hong, D., Gordon, J.A., Tye, Coralee E. , Boyd, Joseph R. , Stein, Gary S.

Mayo Clinic

Genes, Chromosomes and Cancer | March 15, 2019 | Volume: 58 | Issue: 7 | Pages: 484-499

10.1002/gcc.22731 | PMID 30873710 Get It

Cells establish and sustain structural and functional integrity of the genome to support cellular identity and prevent malignant transformation. In this review, we present a strategic overview of epigenetic regulatory mechanisms including histone modifications and higher order chromatin organization (HCO) that are perturbed in breast cancer onset and progression. Implications for dysfunctions that occur in hormone regulation, cell cycle control, and mitotic bookmarking in breast cancer are considered, with an emphasis on epithelial‐to‐mesenchymal transition and cancer stem cell activities. The architectural organization of regulatory machinery is addressed within the contexts of translating cancer‐compromised genomic organization to advances in breast cancer risk assessment, diagnosis, prognosis, and identification of novel therapeutic targets with high specificity and minimal off target effects.
High‐Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta‐Analysis
Samaha, Eslam , Avila, Audrey, Helwani, Mohammad A. , Abdallah, Arbi Ben , Jaffe, Allan S. , Scott, Mitchell G., Nägele, Peter , Jaffe, Allan S.

Mayo Clinic

Journal of the American Heart Association | March 15, 2019 | Volume: 8 | Issue: 6 | Pages: No page available

10.1161/jaha.118.008626 | PMID 30871395 Get It

Background The recent introduction of high‐sensitivity cardiac troponin (hs‐cTn) assays has allowed clinicians to measure hs‐cTn before and after cardiac stress testing, but the hs‐cTn release pattern and potential utility in identifying inducible myocardial ischemia are unclear. We thus conducted a systematic review and meta‐analysis to improve our understanding of hs‐cTn release associated with exercise and pharmacological stress testing. Methods and Results Studies published between January 2008 and July 2016 that reported hs‐cTn change values (high‐sensitivity cardiac troponin T [hs‐cTnT] or high‐sensitivity cardiac troponin I [hs‐cTnI]) in relation to cardiac stress testing were searched and reviewed by 2 independent screeners. Primary outcomes were pooled estimates of absolute and relative hs‐cTn changes after cardiac stress test, stratified by the presence of inducible myocardial ischemia. This meta‐analysis included 11 studies (n=2432 patients). After exercise stress testing, hs‐cTnT increased by 0.5 ng/L or 11% (6 studies, n=406) and hs‐cTnI by 2.4 ng/L or 41% (4 studies, n=365) in patients with inducible myocardial ischemia versus hs‐cTnT by 1.1 ng/L or 18% (8 studies, n=629; P =0.29) and hs‐cTnI by 1.8 ng/L or 72% (4 studies, n=831; P =0.61) in patients who did not develop inducible myocardial ischemia. After pharmacological stress test, hs‐cTnT changed by −0.1 ng/L or −0.4% (6 studies, n=251) and hs‐cTnI by 2.4 ng/L or 32% (2 studies, n=108) in patients with inducible myocardial ischemia versus hs‐cTnT by 0.7 ng/L or 11% (5 studies, n=443, P =0.44) and hs‐cTnI by 1.7 ng/L or 38% (2 studies, n=116; P =0.62) in patients who did not develop inducible myocardial ischemia. Conclusions hs‐cTn rising patterns after exercise and pharmacological stress testing appear inconsistent and comparably small, and do not appear to be correlated with inducible myocardial ischemia.